Sort
40,608 grants matching “prostate cancer”
CENTER FOR BIOMEDICAL RESEARCH
$1,383,495Gilbert Rochon · Tuskegee University · G12 · FY2012 · MD
The Partnership for Native American Cancer Prevention (2 of 2)
$1,383,238David S Alberts · University Of Arizona · U54 · FY2016 · CA
Preclinical Alzheimers Disease Drug Development of Novel MAPK Inhibitors
$1,382,636D. Martin Watterson · Northwestern University At Chicago · U01 · FY2016 · AG
DEFINING CLINICALLY ACTIONABLE SUBTYPES OF CASTRATION RESISTANT PROSTATE CANCER THROUGH EPIGENETIC CELL-FREE DNA ANALYSIS
$1,382,551Emory University · · FY2025 · Defense Health Agency
Molecular Basis for the Pathogenesis of Murine Retroviruses
$1,382,421Sandra K Ruscetti · Division Of Basic Sciences - Nci · Z01 · FY2008 · CA
Research on Prostate Cancer in Men of African Ancestry: Defining the Roles of Genetics, Immunity and Stress (RESPOND)
$1,381,619Christopher Alan Haiman · University Of Southern California · U19 · FY2020 · CA
3/3 Morehouse Sch of Medicine/Tuskegee Univ/University of Alabama Ca Ctr Partnership
$1,380,163Upender Manne · University Of Alabama At Birmingham · U54 · FY2020 · CA
Repository Services for epidemiology studies
$1,380,084David Heimbrook · Leidos Biomedical Research, Inc. · N01 · FY2017 · CA
IGF::OT::IGF CORE INFRASTRUCTURE SUPPORT FOR SURVEILLANCE, EPIDEMIOLOGY AND END RESULTS (SEER)PERIOD OF PERFORMANCE: 05/01/2015 TO 04/30/2016
$1,379,356Brenda Hernandez · Hawaii Univ · N01 · FY2015 · CA
Molecular Imaging of Cancer and Its Response to Therapy
$1,378,841Kenneth A. Krohn · University Of Washington · P01 · FY2012 · CA
Animal Model and Genotyping Core Support Facility
$1,378,522Glenn T. Merlino · Division Of Basic Sciences - Nci · Z01 · FY2008 · CA
Penn's Center of Excellence in Cancer Communication Research
$1,376,507Robert C. Hornik · University Of Pennsylvania · P20 · FY2012 · CA
Advanced Technologies - National Center for Image Guided Therapy (AT-NCIGT)
$1,376,500Clare M Tempany · Brigham And Women'S Hospital · P41 · FY2025 · EB
Clinical Evaluation of an Innovative PSMA-targeted Radiotherapy, CTT1403, in Prostate Cancer
$1,375,908Beatrice Langton-Webster · Cancer Targeted Technology, Llc · R44 · FY2019 · CA
PROSTATE, LUNG, COLO-RECTAL AND OVARIAN (PLCO) CANCER SCREENING TRIAL EXPANSION
$1,375,626Mona N. Fouad · · N01 · FY2007 · CA
THE PROSTATE CANCER CLINICAL TRIALS CONSORTIUM: CLINICAL RESEARCH SITE APPLICATION
$1,375,573Wayne State University · · FY2022 · Defense Health Agency
The Partnership for Native American Cancer Prevention (2 of 2)
$1,375,226David S Alberts · University Of Arizona · U54 · FY2015 · CA
Loma Linda University Center for Health Disparities Res*
$1,375,164Marino De Leon · Loma Linda University · P20 · FY2009 · MD
The Partnership for Native American Cancer Prevention (2 of 2)
$1,374,976David S Alberts · University Of Arizona · U54 · FY2014 · CA
Nanotechnology Linking Biomarkers with Cancer Behavior
$1,374,225Emory University · R01 · FY2004 · CA
Development of Pirenzepine for CIPN
$1,373,465Andrew Mizisin · Winsantor, Inc. · R42 · FY2019 · CA
Prostate, Lung, Colorectal and Ovarian (PLCO) Cancer Screening Trial
$1,371,201University Of Minnesota · N01 · FY2008 · CA
MR-guided focused ultrasound system
$1,368,750Fergus V Coakley · University Of California, San Francisco · S10 · FY2010 · RR
A first in human clinical study of TT101, a synthetic immunomodulatory material to build new functional tissue over exposed bone as a one time treatment for diabetic limb preservation patients
$1,368,090Stephanie Deshayes · Tempo Therapeutics, Inc. · R44 · FY2021 · DK
The Partnership for Native American Cancer Prevention (1 OF 2)
$1,368,009Jani Cheri Ingram · Northern Arizona University · U54 · FY2016 · CA